Dartmouth-Hitchcock Medical Center has begun a clinical trial to research a COVID-19 medication, reports WMUR.
The goal of the medication would be to slow the progression of the virus. At this time, some patients who have tested positive for coronavirus are taking a medication called remdesivir, which was reportedly developed during the ebola outbreak. The clinical trial is being performed both by a team of researchers at the medical facility, and in more than 90 other sites around the world. A group of 25 nurses are giving patients the medicine, with the goal being to see it’s effects on patients with moderate to severe symptoms.
The number of patients receiving the medicine is not being shared at this time.
WNTK Local News 